This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Oct;8(10):563.

doi: 10.1038/nrendo.2012.153. Epub 2012 Aug 21.

Therapy: Glucocorticoid-induced Cushing syndrome increases the risk of cardiovascular events

PMID: 22907138
DOI: 10.1038/nrendo.2012.153

Comment

Therapy: Glucocorticoid-induced Cushing syndrome increases the risk of cardiovascular events

Fiona Mitchell. Nat Rev Endocrinol. 2012 Oct.

. 2012 Oct;8(10):563.

doi: 10.1038/nrendo.2012.153. Epub 2012 Aug 21.

Author

PMID: 22907138
DOI: 10.1038/nrendo.2012.153

No abstract available

PubMed Disclaimer

Comment on

Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study.
Fardet L, Petersen I, Nazareth I. Fardet L, et al. BMJ. 2012 Jul 30;345:e4928. doi: 10.1136/bmj.e4928. BMJ. 2012. PMID: 22846415 Free PMC article.

Similar articles

ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism.
Seki Y, Morimoto S, Saito F, Takano N, Kimura S, Yamashita K, Yoshida N, Bokuda K, Sasaki N, Yatabe M, Watanabe D, Yatabe J, Ando T, Amano K, Kawamata T, Ichihara A. Seki Y, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1788-1791. doi: 10.1210/jc.2018-02268. J Clin Endocrinol Metab. 2019. PMID: 30561712
Genomic insights into Cushing syndrome.
Assié G. Assié G. Ann Endocrinol (Paris). 2018 Jun;79(3):119-122. doi: 10.1016/j.ando.2018.03.011. Epub 2018 May 4. Ann Endocrinol (Paris). 2018. PMID: 29735160 Review.
Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation.
Bouzas EA, Mastorakos G, Friedman TC, Scott MH, Chrousos GP, Kaiser-Kupfer MI. Bouzas EA, et al. Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3497-500. Invest Ophthalmol Vis Sci. 1993. PMID: 8258505
Megestrol-induced Cushing syndrome.
Caparrós GC, Zambrana JL, Delgado-Fernandez M, Díez F. Caparrós GC, et al. Ann Pharmacother. 2001 Oct;35(10):1208-10. doi: 10.1345/aph.10197. Ann Pharmacother. 2001. PMID: 11675847
Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration.
Starkman MN. Starkman MN. Endocrinol Metab Clin North Am. 2013 Sep;42(3):477-88. doi: 10.1016/j.ecl.2013.05.010. Endocrinol Metab Clin North Am. 2013. PMID: 24011881 Review.

See all similar articles

Cited by

Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.
Zhong C, Li N, Wang S, Li D, Yang Z, Du L, Huang G, Li H, Yeung WS, He S, Ma S, Wang Z, Jiang H, Zhang H, Li Z, Wen X, Xue S, Tao X, Li H, Xie D, Zhang Y, Chen Z, Wang J, Yan J, Liang Z, Zhang Z, Zhong Z, Wu Z, Wan C, Liang C, Wang L, Yu S, Ma Y, Yu Y, Li F, Chen Y, Zhang B, Lyu A, Ren F, Zhou H, Liu J, Zhang G. Zhong C, et al. Nat Commun. 2024 Oct 4;15(1):8588. doi: 10.1038/s41467-024-52965-4. Nat Commun. 2024. PMID: 39362888 Free PMC article.

References

1. BMJ. 2012 Jul 30;345:e4928 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group